Health ❯ Healthcare ❯ Drug Safety

Adverse Events

Gastrointestinal Effects Treatment-Emergent Adverse Events Mitapivat Safety Profile Treatment-Related Adverse Events Clinical Trial Results Pirtobrutinib Safety Profile Injection Site Reactions

FDA Clears Dupixent as First Biologic for Young Children With Chronic Spontaneous Urticaria

The move extends a widely used anti-inflammatory drug to a pediatric group with few options.

Dyne’s DMD Drug Hits Primary Endpoint in DELIVER REC, Shows Functional Gains

ASCENT-03 Finds Sacituzumab Govitecan Extends PFS Over Chemotherapy in First-Line PD-L1–Negative TNBC